Recently isavuconazole, an experimental triazole agent, was found to be active against
Aspergillus species. As Aspergillus flavus is the second‐most common Aspergillus species …

Aspergillus flavus is the second most common species causing invasive aspergillosis after
A. fumigatus. In certain countries like India, Sudan, and Saudi Arabia, A. flavus is most …

ABSTRACT NCCLS document M38-P describes standard parameters for testing the
fungistatic activities (MICs) of established agents against filamentous fungi (molds). This …

Voriconazole is a new triazole antifungal agent with potent activity against yeast and molds.
We investigated the in-vitro activity of voriconazole compared with that of other antifungal …

Triazoles are first-line agents for treating aspergillosis. The prevalence of azole resistance in
Aspergillus fumigatus is increasing, and cross-resistance is a growing concern. In this study …

Posaconazole, ravuconazole, and voriconazole are new triazole derivatives that possess
potent, broad-spectrum antifungal activity. We evaluated the in vitro activity of these …

Aspergillus flavus has been frequently reported as the leading cause of invasive
aspergillosis in certain tropical and subtropical countries. Two hundred A. flavus strains …

In vitro combinations of isavuconazole with echinocandins were evaluated against 30
Aspergillus strains with a two-dimensional checkerboard microdilution method and an agar …

The interaction of isavuconazole with immunosuppressors (tacrolimus, cyclosporin A, or
sirolimus) against 30 Aspergillus isolates belonging to the most common species …

We studied the in vitro activity of voriconazole (VCZ) itraconazole (ITZ) and amphotericin B
(AMB) against 216 clinical isolates of Aspergillus spp.(142 Aspergillus fumigatus and 74 …